glp 1 liver function Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty disease? GLP-1_receptor_som_behandling_af_steatotisk_leversygdom - SDU
Description
Obesity is a chronic disease, and people living with obesity deserve treatment options that match the complex biology of their neurometabolic disease, said Ania Jastreboff, MD, PhD, Lead Investigator and Director of the Yale Obesity Research Center
To view or add a comment, sign in 13,878 followers
With Tirzepatide, you can achieve lasting results that help you maintain a healthier weight and improve metabolic function
In some patients, gastrointestinal side effects can be severe enough to lead to treatment discontinuation
